+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacovigilance Europe 2025: Innovation And Integration: Advancing Global Pharmacovigilance In The Digital Age (London, United Kingdom - May 21-22, 2025)

London, United Kingdom
May 21-22, 2025 GMT+1)
  • Conference
  • Graviton International
  • ID: 6041029

13th Annual International Conference And Exhibition In Pharmacovigilance, Regulatory Affairs, Risk Management And Clinical Trials

After witnessing outstanding success in the previous Pharmacovigilance conferences, Pharmacovigilance Europe 2025 will gather the top notch Industry experts from Pharma/Biotech and Clinical Research Organisations from over 15 countries.

Why To Attend This Conference?

- Listen to the top notch Pharma/Biotech Industry pioneers who will deliver the latest cutting edge information.
- A fantastic opportunity to network with the top notch Pharma/Biotech Industry pioneers during the networking sessions.
- Speak out sessions and Panel discussions will provide a great opportunity to ask questions from the expert and find out feasible solutions.

Current Market Of Global Pharmacovigilance

- 15 Billion Global Pharmacovigilance Market to Reach $15 Billion in 2028
- 1.5 Trillion Global Pharmaceutical Market Value $1.5 Trillion

Come and Update with the expanding Global Pharmaceutical Industry and increase awareness on the significant and essential need of Global Pharmacovigilance.

Why Attend Pharmacovigilance Europe?

- A Global Event In Pharmacovigilance
- Ensuring Pharmacovigilance For Global Public Health
- 20+ Expert Speakers From Around The World
- 100’s Pharma/ Biotech Professionals From Over 50 Countries
- Bringing Together The Key Decision Makers Under One Roof
- Over 10 Hours Of Dedicated Networking And Interactive Sessions

Who Should Attend

Pharmacovigilance Europe Congress attracts senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates includes VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following.

  • Pharmacovigilance Risk Management
  • Drug Safety Pharmacoepidemiology
  • Drug Research & Development Clinical Pharmacology
  • Clinical Safety Information And Clinical Data Management
  • Medical Product Safety Assessment Clinical Research & Safety
  • Data Analysis Information Technology
  • Medical Information Health Outcomes
  • Sales And Marketing Clinical Trials & CRO’s
  • Contract Manufacturing

Location

ADDRESS

London
United Kingdom

Venue to be announced shortly.